194 related articles for article (PubMed ID: 27578400)
1. Immunization with electroporation enhances the protective effect of a DNA vaccine candidate expressing prME antigen against dengue virus serotype 2 infection.
Chen H; Zheng X; Wang R; Gao N; Sheng Z; Fan D; Feng K; Liao X; An J
Clin Immunol; 2016 Oct; 171():41-49. PubMed ID: 27578400
[TBL] [Abstract][Full Text] [Related]
2. Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice.
Zheng X; Chen H; Wang R; Fan D; Feng K; Gao N; An J
Front Cell Infect Microbiol; 2017; 7():175. PubMed ID: 28553618
[TBL] [Abstract][Full Text] [Related]
3. Electroporation-Mediated Immunization of a Candidate DNA Vaccine Expressing Dengue Virus Serotype 4 prM-E Antigen Confers Long-Term Protection in Mice.
Sheng Z; Chen H; Feng K; Gao N; Wang R; Wang P; Fan D; An J
Virol Sin; 2019 Feb; 34(1):88-96. PubMed ID: 30790202
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice.
Feng K; Zheng X; Wang R; Gao N; Fan D; Sheng Z; Zhou H; Chen H; An J
Front Cell Infect Microbiol; 2020; 10():87. PubMed ID: 32257963
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
[TBL] [Abstract][Full Text] [Related]
6. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
7. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
8. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
9. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein.
Mota J; Acosta M; Argotte R; Figueroa R; Méndez A; Ramos C
Vaccine; 2005 May; 23(26):3469-76. PubMed ID: 15837370
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
[TBL] [Abstract][Full Text] [Related]
11. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
12. Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4
Zaneti AB; Yamamoto MM; Sulczewski FB; Almeida BDS; Souza HFS; Ferreira NS; Maeda DLNF; Sales NS; Rosa DS; Ferreira LCS; Boscardin SB
Front Immunol; 2019; 10():59. PubMed ID: 30761131
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
[TBL] [Abstract][Full Text] [Related]
14. A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.
Suzarte E; Gil L; Valdés I; Marcos E; Lazo L; Izquierdo A; García A; López L; Álvarez M; Pérez Y; Castro J; Romero Y; Guzmán MG; Guillén G; Hermida L
Int Immunol; 2015 Aug; 27(8):367-79. PubMed ID: 25795768
[TBL] [Abstract][Full Text] [Related]
15. Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery.
Williams M; Ewing D; Blevins M; Sun P; Sundaram AK; Raviprakash KS; Porter KR; Sanders JW
Vaccine; 2019 Jul; 37(32):4444-4453. PubMed ID: 31279565
[TBL] [Abstract][Full Text] [Related]
16. A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection.
Lima DM; de Paula SO; França RF; Palma PV; Morais FR; Gomes-Ruiz AC; de Aquino MT; da Fonseca BA
Vaccine; 2011 Jan; 29(4):831-8. PubMed ID: 21115054
[TBL] [Abstract][Full Text] [Related]
17. Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus.
Brandler S; Lucas-Hourani M; Moris A; Frenkiel MP; Combredet C; Février M; Bedouelle H; Schwartz O; Desprès P; Tangy F
PLoS Negl Trop Dis; 2007 Dec; 1(3):e96. PubMed ID: 18160988
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous Administration of Dengue Vaccines.
Andreata-Santos R; Alves RPDS; Pereira SA; Pereira LR; Freitas CL; Pereira SS; Venceslau-Carvalho AA; Castro-Amarante MF; Favaro MTP; Mathias-Santos C; Amorim JH; Ferreira LCS
Viruses; 2020 May; 12(5):. PubMed ID: 32384822
[TBL] [Abstract][Full Text] [Related]
19. Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus.
Lazo L; Izquierdo A; Suzarte E; Gil L; Valdés I; Marcos E; Álvarez M; Romero Y; Guzmán MG; Guillén G; Hermida Cruz L
Microbiol Immunol; 2014 Apr; 58(4):219-26. PubMed ID: 24689365
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a Candidate DNA Vaccine Based on the prM/E Genes of a Dengue Type 2 Virus Cosmopolitan Genotype Strain.
Putri DH; Sudiro TM; Yunita R; Jaya UA; Dewi BE; Sjatha F; Konishi E; Hotta H; Sudarmono P
Jpn J Infect Dis; 2015; 68(5):357-63. PubMed ID: 25766602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
